Table 1.

Effect of Epoxomicin on AA Release from Rat Glial, Human Colon Carcinoma and Human Breast Carcinoma Cells.

Cell Type	% AA Release
	MEM/BSA control	With epoxomicin
Rat glial (C-6)	9.0 ± 0.07	11.4 ± 0.28
Human Colon Carcinoma (HT-29)	7.8 ± 0.05	9.4 ± 0.33
Human Breast Carcinoma (BT-20)	12.1 ± 0.35	14.2 ± 0.31

Cells were incubated in the presence and absence of 4.5 μM epoxomicin for 6-h, 12-h or 9-h (C-6, HT-29, BT-20 respectively). Analyses were performed with quadruplicate (C-6 and HT-29) or quintuplicate (BT-20) dishes. All values are expressed as Mean ± SE (n = 4 or n = 5). All data with epoxomicin are statistically significant vs MEM/BSA.